Urinalysis & Toxicology

Home Test Kit Detects Bladder Cancer with 88.8% Accuracy

Researchers developed a urine-based diagnostic kit for bladder cancer, offering a solution for early detection and monitoring at home.

Urinalysis & Toxicology

Intelligent Bio Solutions Fingerprint Drug Test Advances on FDA 510(k) Pathway

Intelligent Bio Solutions completed biocompatibility testing for its fingerprint drug screening system, advancing toward 510(k) clearance.

Urinalysis & Toxicology

Researchers Discover Urine-Based Test to Detect Head and Neck Cancer

Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.

New Forensic Toxicology Tech for the Detection of Drugs of Abuse

Dec 1, 2023 | Urinalysis & Toxicology

This product design aims to transform workflows, expediting results for labs tasked to provide care for victims of drug-facilitated crimes.

Urine Biomarkers Can Outperform Serum Biomarkers in Certain Diseases

Nov 1, 2023 | Urinalysis & Toxicology

Researchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.

Fentanyl POC Test Instrument Gets FDA Clearance

Jul 26, 2023 | POC Instruments, Urine Analyzers

Shenzhen Superbio Technology received FDA clearance for a point-of-care instrument intended for the detection of fentanyl in human urine.

Xylazine Testing Added to NC Lab’s In-House Menu

Jul 11, 2023 | Urinalysis & Toxicology

Keystone Lab has officially added xylazine to its in-house urine clinical toxicology menu.

Combination Fentanyl and Xylazine Test Strip to Combat Opioid Deaths

Jun 30, 2023 | Urinalysis & Toxicology

HarmGuard FX is a single, low-cost test strip that provides an affordable, reliable way for people to test for fentanyl and xylazine.

Colli-Pee Self-Sampling Device Could Improve HPV Screening Access

Jun 15, 2023 | Cervical (HPV), Urinalysis & Toxicology

Self-sampling with the Colli-Pee device could significantly expand access to cervical cancer screening for underserved and rural populations.

Fingerprinting Drug Screening System to Be Used for Fentanyl Testing

May 16, 2023 | Urinalysis & Toxicology

Intelligent Bio Solutions Inc. has announced plans to add fentanyl to the substances detected by its Fingerprinting Drug Screening System.

EarlyTect BCD a Breakthrough Device for Bladder Cancer Detection

May 12, 2023 | Urinalysis & Toxicology

FDA has granted Breakthrough Device Designation to EarlyTect BCD as a non-invasive, urine-based diagnostic for bladder cancer in patients with hematuria.

Xylazine Testing Launched at Philadelphia Lab

May 11, 2023 | Urinalysis & Toxicology

Parkway Clinical Laboratories Inc. (PCL), has launched Xylazine testing via LCMSMS confirmation testing on urine specimens.

Clinisys Acquires Promium to Expand Diagnostics Capabilities

May 10, 2023 | Company News, Urinalysis & Toxicology

Clinisys has acquired Promium, a provider of laboratory information management systems for environmental analytical testing laboratories.

Genomic Urine Test Detects Bladder Cancer 12 Years Before Symptoms Appear

May 4, 2023 | Urinalysis & Toxicology

This genomic urine test uses next-generation DNA sequencing and machine learning to analyze urine for mutations across 60 genes linked to bladder cancer while also measuring the entire genome.

Studies on UroAmp Test for Bladder Cancer to be Presented at 2023 AUA Meeting

Apr 25, 2023 | Urinalysis & Toxicology

Convergent Genomics’ UroAmp genomic urine test for bladder cancer will be the subject of two new studies being presented at the 2023 American Urological Association Annual Meeting.